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ABSTRACT 
Background 
After the introduction of the Metasul system by Weber in 1988, total hip arthroplasty (THA) 
with metal-on-metal (MoM) bearings became increasingly popular in the 1990s. MoM 
bearings aimed to reduce the problem of aseptic loosening associated with polyethylene wear 
particles from conventional polyethylene cups. The following introduction of hip resurfacing 
added positive factors as bone sparing and large caliber heads, reducing the risk of disloca-
tions. After almost two decades of increasing use of MoM prostheses, reports of implant 
failure and adverse reactions to metal became numerous. Starting in 2009, a dramatic 
decrease in the use of MoM bearings has been seen. 
Patients and methods 
Paper I was an experimental in vitro study measuring the amount of metal worn off from a 
MoM prosthesis with a 28-mm diameter head, using a hip simulator. Papers II-IV were all 
based on a prospective, randomized, controlled clinical trial including 85 patients allocated 
into two groups. One group was operated with a MoM prosthesis while the other group 
received a similar prosthesis with a conventional metal-on-polyethylene (MoP) bearing. All 
components were cemented and 28-mm heads were used. Clinical outcome and serum metal 
ion concentrations were evaluated at short-term (three, six, 12 and 24 months, paper II), 
medium-term (7 years, paper III) and long-term (16 years, paper IV) follow-up. Overall long-
term survival of the implants was estimated after a mean of 16 years (paper IV). 
Results 
A so-called run-in phase with higher initial wear from MoM implants was seen in the joint 
simulator testing within the equivalent of the first year of use. As expected, patients with 
MoM bearings showed higher cobalt (Co) and chromium (Cr) ion concentrations compared 
to patients in the MoP group at all time-points from 3 months to 16 years postoperatively. 
The percentage of circulating HLA DR+ CD8+ T-cells was higher in the MoM compared to 
MoP group (10.6 vs. 6.7 %; p = 0.03) and was positively correlated to systemic concentra-
tions of Co and Cr. At the last follow-up 16 years after the index surgery, radiographic result 
and clinical performance was similar in both groups (Harris hip score: MoM=91, MoP=95, 
p=0.28) and no difference between groups was seen regarding implant survival (MoM: 93 % 
[95% CI: 83-100%]; MoP: 95 % [95% CI: 87-100%], p=0.99). 
Conclusions 
This thesis evaluated a 28-mm head THA, comparing a MoM bearing with a conventional 
MoP articulation. Both articulations performed equally well in regard to long-term implant 
survival and clinical outcome. Due to the absence of clinical superiority of the MoM bearing 
and concerns about biological effects of the MoM articulation, the use of MoP articulations is 
recommended. 
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1 BACKGROUND 
1.1 THE HISTORY OF TOTAL HIP ARTHROPLASTY 
Ever since surgeons in the 1920s and -30s started experimenting with the implantation of 
different materials covering the femoral head, the orthopaedic community has strived for 
perfection when it comes to materials, designs and techniques of hip arthroplasty. The first 
hip arthroplasty is considered to be an implanted stainless steel cup covering the femoral 
head, described by Smith-Petersen in 1938.1 The first total hip arthroplasty (THA) replacing 
the entire joint by mechanical parts was described only some years later by Wiles.2 
The implant design evolved in several directions, including for example the McKee-Farrar 
metal-on-metal (MoM) THA made from a cobalt-chromium (CoCr) alloy, introduced in 1956 
and used, with some modifications, for decades.3 When Charnley introduced the low friction 
arthroplasty, THA became even more successful over time.4, 5 Charnley’s superior results led 
however to the discontinuation of the McKee-Farrar prosthesis and similar designs on the 
market. The concept of a metal femoral component articulating against a polyethylene cup 
would however inevitably lead to attrition of the cup component, especially in the younger, 
more active patient. A fraction of implants failed due to so-called aseptic loosening of the 
components, which was later, in part, attributed to tissue reactions to polyethylene wear 
particles from the cup.6 In 1998, Weber developed and started using a second generation 
MoM arthroplasty, the Weber-Metasul, which was supposed to solve the problem of 
polyethylene wear particles with no apparent side effects.7 
1.2 SECOND GENERATION METAL-ON-METAL TOTAL HIP ARTHROPLASTY 
AND RESURFACING 
When the second-generation MoM THAs and resurfacing implants were released onto the 
market in the 1990’s, it was expected that aseptic loosening due to polyethylene particles 
would be drastically reduced. Many surgeons in the orthopaedic community promptly 
embraced the hip resurfacing design as they were appealed by the idea of bone preservation 
of the proximal femur, combined with a large femoral head which reduced the risk of 
dislocation. The reduced risk of dislocation was one of the reasons for implant manufacturers 
to develop THA systems with traditional stems and all-metal bearings with large-diameter 
heads and cups. This made it possible to revise only the femoral component of a resurfacing 
system while keeping the acetabular component. Revision of the cup would otherwise often 
prove to be a challenge because of its big size. By 2006, 35 % of the implanted hip 
arthroplasties (including hip resurfacing) in the U.S. were MoM, increasing to a peak of 40 % 
in 2008 and declining numbers ever since.8, 9 Most all-metal implant systems are made from 
high carbon CoCr alloys because of their properties, making them well suited for use in hard, 
low-friction surfaces.10 
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1.3 COMPLICATIONS RELATED TO METAL-ON-METAL IMPLANTS 
The re-introduction of the MoM concept did not however improve the results after THA. 
Over the years it became more apparent that aseptic loosening was associated with MoM 
bearings as well. Another important cause of implant failure and subsequent revision was, 
and still is, localized pain around the prosthesis, often associated with tumour-like tissue 
reactions. Lymphocytes and giant cells were found in tissues surrounding failed MoM pro-
stheses in several studies and case reports.11 Suspicions arose of an association between the 
reactions and metal nanoparticles in the soft tissue surrounding the implant.12 The histology 
of the tissue was shown to be rather different from the granulocyte mediated loosening that 
polyethylene particles were believed to cause in MoP implants.6, 11, 13 
An increasing number of publications raised the issue of soft tissue complications emerging 
in patients presenting with local pain within months or years after surgery with a resurfacing 
implant, and to some extent after stemmed MoM THA.14 Several studies have since then 
investigated this phenomenon and described it in greater detail. The following terminology 
has been taken into general use: 
• Metallosis – meaning the dark discoloration of soft tissue surrounding the implant 
related to trace metals worn off and released from it.15 
• Pseudotumours – a solid or cystic mass of soft tissue adjacent to the prosthesis some-
times presenting with local symptoms of pain or swelling, often with a histological 
appearance of ALVAL, giant cells and necrosis.14 
• ALVAL – Aseptic Lymphocytic Vasculitis-Associated Lesions, a histological dia-
gnosis of soft tissue that can be present with or without metallosis and pseudo-
tumours.11 
• ARMD – Adverse Reaction to Metal Debris, which all of the three previous 
conditions are examples of.16  
It is yet unknown whether these conditions are a result of cellular toxicity of metals or of 
hypersensitivity to them.12 It is now clear that the conditions are associated with high levels 
of metal ions in local tissues and elevated levels in serum, but far from always correlating to 
complications in a dose-dependent manner.17-19 
Several MoM prosthesis systems using large caliber heads have shown high failure rates and 
the use of these systems has therefore diminished considerably.20, 21 Studies have shown 
major variations in survival rates for different hip resurfacing implants. Some systems 
performed very poorly and were retracted from the market due to high rates of early failure, 
whereas other systems continue to perform well over time.22 A large register study on hip 
resurfacing implants, found evidence that the general survival rate of these prostheses was 
only at acceptable levels in male patients with large caliber head implants, even when a 
resurfacing system well-known to be of inferior design, was excluded from the analysis.23 For 
men requiring smaller head sizes and for all women, hip resurfacing is strongly discouraged 
based on the outcome of that and many other studies. 
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In contrast, MoM systems using small heads, like the 28-mm bearing studied in this thesis, 
have performed over-all well, with implant survival rates at, or close to, the level of tradi-
tional MoP systems.15, 24 
1.4 WEAR FROM METAL-ON-METAL IMPLANTS 
The origin of metal particles in the surrounding tissue and ions in blood and serum are 
primarily worn off from the bearing surfaces in resurfacing implants. However, in MoM 
THA, the source can also be the metallic interface between the trunnion of the neck and the 
head in modular prostheses, as a result of corrosion or mechanical wear. This can explain the 
discrete but measurable elevation of metals in serum that can be seen after implanting 
modular MoP THAs.13 
All MoM implants produce wear debris of metallic nanoparticles and ions through both 
mechanics and corrosion. Particles are two orders smaller than polyethylene (PE) particles, 
which may explain the different immune response in vivo, where PE has been shown to 
evoke response from granulocytes while lymphocytes seem to respond more to metals12, 13, 15.  
Risk factors associated with higher wear rates are:25-28 
• small resurfacing heads 
• equatorial design, where the components apply friction around the diameter of the 
head, as apposed to polar design where friction is primarily applied to the central head 
• cup implantation at a high inclination angle, leading to edge loading of the bearing 
• low carbon content in the alloy composition leading to a rougher surface 
Implants with these characteristics have a higher risk of early failure and need of revision. It 
is not concluded whether this is because of the higher local load of metal wear debris or if the 
reason is mainly mechanical.15 
1.5 FACTS ON COBALT AND CHROMIUM 
Cobalt (Co, atomic number 27) is a ferro-magnetic transition metal of silvery gray appear-
ance. Like iron and chromium, it’s a hard metal with a high melting and boiling point. The 
Swedish chemist Georg Brandt discovered it in 1739. It is the 33rd most common element on 
earth and usually only found in small amounts, hardly worth unearthing on its own. Co is 
never found in pure form, only in minerals where it is combined with other elements. In many 
places Co is mined together with silver, copper or nickel. The mixed ore usually also contains 
arsenic and thus becomes poisonous when heated, which led to unwanted effects when 
extracting the precious metals. Co was blamed for these adverse effects and was named from 
the German word “Kobold” that translates to “mean goblin”. 
Co has been used by humans for thousands of years and even the ancient Egyptians made 
blue colored glass and pottery from Co salt.29 
Henrik Dahlstrand 
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There is only one known use for Co in the human body, which is in the form of cobalamin 
(vitamin B12), an essential co-factor in different enzyme reactions in vivo where methyl 
groups are transferred between biologically active compounds. The reactions take place in 
every cell in the human body and most important is the transformation of homocysteine to 
methionine. Cobalamin deficiency leads to neuropathy and anemia.30 
Negative biological effects of Co administered to humans was first described in 1966 in 
Quebec after a brewery started adding Co to its beer to improve foaming performance. 
Investigations were initiated because of a sudden onset of a minor local epidemic of acute 
cardiomyopathy in alcoholics. At first, the health care authorities were taken by surprise by 
the spread of a new type of cardiomyopathy and the clinical findings were different from the 
known form of cardiomyopathy caused by alcohol alone.31 Even with considerable beer 
intake the amount of ingested Co was not more than 20-25 % of the doses used therapeuti-
cally at the time to treat anemia. It was later concluded that the combination of malnutrition, 
excess alcohol and added Co became cardiotoxic, leading to cardiomyopathy. 
There have been case reports of cardiomyopathy in patients following MoM THA, mainly 
after resurfacing. No causality has been established between the condition and the implant, 
even though reports state improvement in cardiac function after hip revision where the MoM 
implant has been removed.32 
There is no conclusive evidence of genetic toxicity of Co to human DNA, but it is marked as 
“possibly carcinogenic to humans” by the International Agency for Research on Cancer, 
IARC, an agency under the World Health Organization.33, 34 
Chromium (Cr, atomic number 24) is a silvery shining transition metal. It was discovered in 
1761 by the German prospector JG Lehmann, but it was not until 1797 that the French 
chemist LN Vaquelin first isolated it in metallic form. As a transition metal, Cr has the 
potential of creating alloys with similar metals, like Co. It does not react readily with other 
substances and is therefore resistant to corrosion, a trait used when coating metal details 
(“chrome”) in cars for example. In various alloys, including the ones used in orthopaedic 
implants and so-called stainless steel, Cr has the role of reducing corrosion.35 
The systemic toxicity of Cr (III) derived from hip implants has been debated, but to most 
extent been ruled out. The role of Cr in local tissue reactions around hip implants is yet 
unclear and Co is believed to play a more important role.36 The major concern for Cr as a 
health hazard, is the shown relation between inhaled Cr (VI) and carcinogenesis in the 
respiratory tract.37 This is however the case only with hexavalent Cr and not with the trivalent 
form present in the alloy of implants. It is unlikely for trivalent Cr to be physiologically 
oxidized to the hexavalent form at neutral pH in vivo. The trivalent form cannot move freely 
across lipid membranes.36 
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1.6 PRESENT USE OF METAL-ON-METAL IMPLANTS 
It is estimated that 755,000 MoM hip bearings were implanted in the U.S. alone between the 
years 2000 and 2010, of which 2008 was the year with the highest incidence. 84 % of the 
implants were primary THAs, 12 % revision THAs and 5 % hip resurfacing THAs.9 A similar 
development was seen in Great Britain.38 Many of the questions mentioned above, about 
safety and reliability of MoM bearings together with poor implant survival results, caused 
severe concern for clinicians, orthopaedic organizations and authorities. Even though there 
are MoM implant systems that are performing well in long-term follow-ups, several systems 
were recalled between 2008 and 2011 due to poor results.39 In 2011 and 2012 the Food and 
Drug Administration (FDA) in the U.S. and the Medicine and Healthcare products Regu-
latory Agency (MHRA) in Great Britain issued recommendations to surgeons on stricter 
patient selection (FDA) and even advising against all use of MoM bearings (MHRA), 
suggesting protocols for life long clinical follow-up of patients with regular measurements of 
systemic Co and Cr concentrations.40-43  
Since these concerns were raised, THA surgery with MoM bearings have been drastically 
diminished. According to data from the Swedish Hip Arthroplasty Register, only 0.2 % of the 
THAs implanted in 2014 had MoM bearings, hip resurfacing included.44 However, it is 
estimated that over one million patients world-wide, presently are living with an implanted 
MoM device.8 One may speculate that more than a few of them (and their orthopaedic 
surgeons) are wondering, even with a well-functioning implant, what the long-term effects 
may be of the metals being continuously released by their bearings. 
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2 AIMS OF THE THESIS 
The overall aim of this thesis was to evaluate a MoM THA with a 28-mm head by testing it 
both in vitro with a joint simulator and in vivo in patients. 
The specific aims of this thesis were to investigate: 
1. the presence of a run-in phase of metal wear from a MoM hip device in vitro, during 
the equivalent of the first four years of use in vivo (paper I). 
2. the systemic load of metal ions over time in THA patients with a MoM compared 
with a MoP bearing (papers II-IV). 
3. if systemic metal ion concentrations in patients after THA correlate with 
immunological reactions (paper III). 
4. the clinical performance and long-term survival of a MoM THA compared to a 
conventional MoP THA (paper IV). 
 

Evaluation of a metal-on-metal total hip arthroplasty 
 9 
3 PATIENTS AND METHODS 
3.1 STUDIED IMPLANTS AND SURGICAL TECHNIQUES IN PAPERS I-IV 
In paper I, six hip simulators were equipped with 28-mm Metasul heads articulating against 
cups consisting of a Metasul liner in a polyethylene (PE) backing (Sulzer; Winterthur, 
Switzerland). 
In papers II-IV, in the setting of a 
randomized, controlled study, the 
intervention group received THAs 
with the same MoM 28-mm Metasul 
bearing as investigated in paper I, 
while the control group received a 
MoP bearing with a 28-mm metal 
head (Protasul, Sulzer) and an all-
polyethylene cup (Müller, Sulene, 
Sulzer). The PE was made of ultra-
high molecular weight polyethylene 
(UHMWPE), but not highly cross-
linked. 
In both groups, the same cemented 
stem was used: the MS-30 (Sulzer) 
with a matte surface finish. Both stem 
and cup were cemented with high 
pressure technique using Palacos bone 
cement (Heraeus; Hanau, Germany). 
All surgeries were performed using a 
posterior approach, and most were 
performed by one senior surgeon. The 
MS-30 stem and Metasul bearing are 
shown to the right. 
Both Metasul and Protasul implants 
are made from similar wrought, high 
carbon, CoCr alloy. The alloy consists 
of a minimum of 50 % Co, 26-30 % 
Cr, 7 % molybdenum and 1 % man-
ganese and nickel, respectively. The 
only difference between the two 
alloys, is that Metasul has a higher amount of carbon (0.2-0.25 %) compared to Protasul 
(0.05-0.08 %), which allows for the surfaces of the Metasul implants to be polished into a 
slightly harder and smoother surface compared to Protasul. 
Henrik Dahlstrand 
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3.2 SIMULATOR STUDY, PAPER I 
In this tribological study, the six Metasul implant pairs were mounted in servo-hydraulic hip 
simulators of orbital type and run at one Hz for a total of 4.2 million cycles, which is 
estimated to be the equivalent of four years of moderate activity in vivo. Alpha calf serum 
diluted to 50 % concentration was filtered and used as a synovial fluid substitute between the 
head and the cup. Temperature and humidity of the simulator laboratory was maintained at 
narrow intervals and loss of lubricant from evaporation was replaced by distilled water. Wear 
from the metal components was measured at regular intervals: every 50,000 cycles up to 
300,000, every 100,000 cycles up to 700,000 and above that every 250,000 cycles. Wear was 
calculated by measuring weight-loss of components using Sartorius-type scales. Weight-loss 
was then converted to volumetric wear expressed as cubic millimeter per million cycles. 
3.3 PATIENTS IN THE CLINICAL STUDY, PAPERS II-IV 
166 patients referred to the Orthopaedic Department at the Karolinska Hospital during 1998 
and 1999 were assessed for participation in the study. Inclusion criteria were age between 40 
and 75 years and need for THA because of pain due to primary osteoarthritis of the hip. 
Exclusion criteria were: declining to participate in the study, previous joint replacement or 
surgery with metal osteosynthesis, weight over 105 kg, previous infection or surgery in the 
affected hip, local or general osteoporosis, intake of steroids during more than three months 
during the last year, alcohol or drug abuse and mental disorders including dementia. After 
application of these criteria a cohort of 85 patients were included in the study. They were 
randomized into two groups by a computer application using the minimization method,45 
allocating 41 patients into an intervention group receiving the MoM articulation and 44 
patients into a control group receiving the MoP bearing (Figure 1). The algorithm in the 
application is designed to use information about body weight, smoking habits, sex and age to 
ensure equal size and composition of cohorts. Statistical analysis of the two groups was 
performed and did not show any significant differences regarding these variables. Patient 
characteristics are shown in Table 1. 
Table 1. Patient characteristics preoperatively. Total numbers or mean values  
(± standard deviation) and significance (p) of the difference (Independent t-test). 
Parameter  MoM (n=41) MoP (n=44) p value 
Age at surgery, years 64.8 ± 6.6 66.6 ± 7.2 0.23 
Male sex, n 20 19 0.67I 
Smokers, n 7 6 0.77I 
Body mass index, kg/m2 26.8 ± 3.5 26.5 ± 3.7 0.72 
Harris hip score 38.0 ± 12.5 37.3 ± 12.5 0.80 
MoM=metal-on-metal, MoP=metal-on-polyethylene, I Fisher’s exact test 
Follow-up visits were performed at three, six, 12 and 24 months (paper II), at a mean of 
seven years (mean 82 months, range 72-97 months; paper III) and finally at a mean of 16 
years (range 15-17 years; paper IV). Patients who had additional joint replacement surgery 
after the index operation were excluded from follow-up until seven years. The reason for this 
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exclusion was to minimize the risk that additional metal exposure would confound the results 
of the metal ion concentrations. At 16 years, patients with additional implants were not 
excluded from the analysis because of the small number of patients still available for follow-
up. The proportion of patients with additional implants in each group was similar at 16 years 
(MoM=nine out of 14 patients, MoP=10 out of 16 patients; p=0.61). None of the patients in 
the study cohort had an additional MoM hip implant at any time. At the final follow-up (16 
years, paper IV), the frequency of revision and other re-operations in the patient cohort since 
the index operation was confirmed in the Swedish Hip Arthroplasty Register. 
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3.4 ANALYSES OF METAL ION CONCENTRATIONS, PAPERS II-IV 
All concentrations of metal ions reported in papers II-IV were analyzed by an accredited 
external laboratory specialized in trace metal analyses, ALS Scandinavia AB (formerly 
SGAB Analytica AB, Lulea, Sweden). 
Internal standards and calibration solutions used were prepared by diluting one mg/ml single-
element standard solutions (SPEX Plasma Standards, Edison, NJ, USA), taking inter-element 
compatibility into account. 
Quality control samples were made by diluting 10 mg/L multi-element standard solutions (PE 
Pure Plus Atomic Spectroscopy Standard, Norwalk, USA) to check the concentrations of the 
calibration standards. Nitric acid (Merck, Darmstadt, Germany) was used after additional 
purification by sub-boiling distillation. Dilution of samples, blanks and standards was made 
with distilled de-ionized water (DDIW). The analysis of samples was performed after dilution 
(1+9) with 0.14 M HNO3 in DDIW. This dilution factor provides a compromise between the 
necessity to decrease matrix effects and the requirement for lowest possible detection limits 
for trace elements. 
Samples were collected preoperatively and at three, six, 12 and 24 months postoperatively 
(paper II), at seven years (paper III) and at the 16-year follow-up (paper IV). They were 
drawn using an intravenous cannula with the stainless-steel needle removed and the first five 
mL of blood discarded. The containers used were 10 mL polypropylene tubes with sodium 
heparin (Teklab Ltd, Durham, United Kingdom) from the same batch, except from at 16 
years when five mL glass containers without additive were used (Vacutainer, BD, New 
Jersey, USA). This means that plasma was separated up until the seven-year follow-up and 
serum was used at the later follow-up at 16 years. 
Blood samples were then centrifuged at 2000 G for 10 minutes, after which plasma (or serum 
at the 16-year follow-up) was transferred to acid-washed polypropylene test tubes and stored 
at - 20°C until analysis. 
Metal ion concentrations were measured by high-resolution inductively coupled plasma mass 
spectrometry using commercially available devices. For all samples except the ones collected 
at 16 years, the same device was used (Element, Finnigan-MAT, Bremen, Germany). The 
detection limit was 0.2 µg/L (4 nmol/L) for Cr and 0.05 µg/L (0.8 nmol/L) for Co. At the 16-
year follow-up, another device was used (Element 2, Therma Scientific, Waltham, USA). The 
detection levels were 0.05 µg/L for Co and 0.5 µg/L for Cr. 
To facilitate comparison with other studies, ion concentrations were presented in micrograms 
per liter, µg/L, sometimes referred to as ppb in the literature. 
3.5 RADIOLOGICAL ASSESSMENT 
Follow-ups at two, seven and 16 years included anteroposterior and lateral radiographs of the 
investigated hips as well as anteroposterior pelvic radiographs. All radiographs were 
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compared to those taken in the first two days after surgery. The radiographs taken at two and 
seven years were examined by a radiologist for periprosthetic osteolysis around implants and 
liner wear. At 16 years, the radiographs were analyzed for radiolucent lines in the three 
acetabular zones described by DeLee and Charnley and in the seven femoral zones described 
by Gruen et al.46, 47 Femoral stem subsidence was measured by the distance between the 
lateral part of the stem in relation to the greater trochanter. Subsidence exceeding five mm 
was considered as migration. The cup inclination angle was also determined.  
3.6 IMMUNOLOGICAL ANALYSES 
In paper III, subpopulations of leukocytes were measured by flow cytometry on a Coulter 
EPICS-XL-MCL, using commercially available antibodies (CD3, CD8, CD45, CD4: 
Tetracrome Beckman Coulter, Bromma, Sweden cat. no. 6607013; CD3, CD16/56, CD45, 
CD19: Tetracrome cat. no. 6607073 and Becton-Dickinson cat. no. 332779; HLA DR: 
Becton-Dickinson cat. no. 6604366; CD4: Becton-Dickinson cat. no. 345768; CD8: Dako 
cat. no. C7079). Results were reported as numbers/nL or as percentages. Immunoglobulins 
and IgG subclasses were analyzed by nephelometry (Dade-Behring BN II, Siemens). A 
commercially available kit (The Binding Site Group Ltd., Birmingham, UK) was used to 
determine subclasses. The results were expressed in g/L. 
3.7 HARRIS HIP SCORE 
Clinical function of the operated hips was reported in papers II-IV, using the Harris hip score 
(HHS).48 The Harris hip score is calculated from range of motion and absence of deformity, 
combined with the answers to questions in two dimensions: pain and function. Since the 
study started, there have been discussions about the use of the HHS in orthopaedic research, 
including criticism concerning a “ceiling effect” of the result.49 All patients in papers II-IV 
were evaluated clinically with the subsequent calculation of HHS preoperatively and at all 
follow-up visits. The investigator carrying out the examination was blinded as to the type of 
bearing the patient had received. 
3.8 SHORT FORM 36 
The Short Form 36 collected by a physiotherapist preoperatively and follow-ups at 12 and 24 
months were reported in paper II. SF-36 consists of 36 items divided into eight domains that 
can be aggregated into summaries based on physical and mental health.50 The domains are: 
• Bodily pain 
• Physical functioning 
• Role limitations due to physical health 
• General health 
• Mental health 
• Vitality 
• Social functioning 
• Role limitations due to emotional health. 
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3.9 ETHICS 
Paper I did not include patients, animals or human tissue and did not require ethical permits. 
The study protocols of the clinical study reported in papers II-IV were reviewed and 
approved by the Ethics committee of the Karolinska Hospital and the Regional ethical review 
board of Stockholm at Karolinska Institutet, respectively. Informed consent was given by all 
participants and the study was conducted in accordance with the Helsinki Declaration.51  
3.10 STATISTICAL METHODS 
Variables were summarized using standard descriptive statistics such as frequencies, means, 
medians, standard deviations and 95 % confidence intervals. The level of significance (two-
tailed) was 0.05 in all analyses. Fisher’s exact test was used for analysis of categorical 
variables when expected counts were five or less, when higher frequencies were expected the 
Chi square test was used. 
A power analysis preceded the planning of the clinical study in papers II-IV, indicating that 
20 patients per group would be sufficient to detect differences in metal ion concentrations 
(our primary endpoint) of one standard deviation with a power of 80 %, given a two-tailed p-
value of 0.05. 
The distributions of metal ion concentrations were positively skewed which suggested the use 
of nonparametric methods when comparing groups. Except for a few outliers with higher ion 
concentrations, most subjects were found at the lower ends of concentrations just above the 
detection limit. Metal ion concentrations were transformed to near-normal distributions by 
calculating natural logarithms. This allowed for the use of parametric comparisons between 
means and 95% confidence intervals using independent t-test. 
The investigation of immunological parameters in paper III was not intended at the beginning 
of the study, but became relevant at a later stage. Thus, the power estimation was not based 
on this secondary endpoint. Most immunological parameters were normally distributed. The 
absence of baseline data demanded that inter-group comparisons of immunological para-
meters were performed using the independent t-test. Pearson’s correlation coefficient was 
used in performing correlation analysis of logarithmically transformed metal ion concen-
trations with immunological parameters. 
Group comparisons of means and 95 % confidence intervals in papers II-IV were made using 
an independent t-test. 
Implant survival in paper IV was estimated by the Kaplan-Meier method. The Mantel-Cox 
log rank test was used to investigate whether survival estimates differed between groups 
Statistical analyses for this thesis were performed using the SPSS software version 23 (SPSS 
inc., Chicago, Illinois, USA). 
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4 RESULTS 
4.1 WEAR RATE IN JOINT SIMULATOR, PAPER I 
Wear from the investigated components showed a similar wear rate pattern with an 
accelerated initial phase of high wear followed by a lower steady state wear rate. This initial 
so called “run-in” phase ended between 0.670 and 0.925 million cycles (Mc). 
The average wear from the liners in the run-in phase was 0.72 mm3/Mc (R2 >0.94) which was 
reduced to 0.28 mm3/Mc (R2 >0.96) in the subsequent steady-state. One liner (L6) deviated 
from this pattern and continued to have a high wear rate throughout the study. 
The heads exhibited similar wear phases with a high wear run-in phase, averaging 1.50 
mm3/Mc (R2 >0.98) and a reduced average wear steady-state of 0.69 mm3/Mc (R2 >0.99). 
Two of the heads (H4 and H6) did not seem to reach the lower steady-state and continued to 
show a high wear rate throughout the study. 
When comparing the total wear rate from the combined head-liner pairs, three noticeable 
groups were seen related to their respective wear rate: a low, an intermediate and a high wear 
rate group (Table 2). 
 
Table 2. Summary of volumetric wear rates in run-in and steady-state phases. 
Implant 
pair 
Wear rate RI 
H+L, mm3/Mc 
Wear rate SS 
H+L, mm3/Mc 
Total wear 
head, mm3 
Total wear 
liner, mm3 
Wear rate 
group 
H3/L3 1.31 0.53 1.4 0.6 Low 
H2/L2 3.06 0.48 1.8 0.9 Low 
H1/L1 1.61 0.20 2.9 1.0 Medium 
H5/L5 3.03 1.36 3.3 0.8 Medium 
H4/L4 2.15 0.87 5.3 1.7 High 
H6/L6 2.17 2.44 6.2 4.6 High 
H=Head, L=Liner, RI=Run In, SS=Steady State, Mc=Million Cycles. 
 
During the writing of this thesis, an error was discovered in the result section of paper I 
published in J Biomed Mater Res. In the paper’s result table corresponding to Table 2 above, 
rows are designated the wrong pairs of heads and liners in column one. In Table 2 above, this 
unfortunate error has been corrected.  
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4.2 CONCENTRATION OF COBALT AND CHROMIUM, PAPERS II-IV 
Mean concentrations of Co and Cr in plasma and serum were low in both groups pre-
operatively. No difference was shown between groups. From the first postoperative control at 
three months and at all subsequent measurements to the last control at 16 years, patients in 
the MoM group showed higher levels of both Co (Table 3 and Figure 2) and Cr (Table 4 and 
Figure 3). The difference between groups was statistically significant at all time-points. 
 
Figure 2. Concentration of cobalt over time, mean and 95 % CI. 
 
 
Table 3. Mean cobalt concentration, 
µg/L and p-value (independent sample T-
test on log transformed values) 
 MoM MoP p 
Preop 0.14 0.15 0.264 
0.25 year 0.87 0.19 <0.001 
0.5 year 1.07 0.20 0.03 
1 year 0.96 0.24 <0.001 
2 years 1.01 0.37 <0.001 
7 years 1.10 0.32 0.008 
16 years 1.51 0.35 <0.001 
Table 4. Mean chromium concentration, 
µg/L and p-value (independent sample T-
test on log transformed values) 
 MoM MoP p 
Preop 0.31 0.29 0.644 
0.25 year 0.98 0.36 <0.001 
0.5 year 1.26 0.39 0.007 
1 year 1.15 0.36 <0.001 
2 years 0.99 0.44 <0.001 
7 years 1.16 0.42 0.007 
16 years 2.20 1.04 0.047 
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Figure 3. Concentration of chromium over time, mean and 95 % CI. 
 
 
The increased mean concentration of Cr seen at 16 years was statistically significant in the 
MoP group compared to the mean concentration seen at seven years (p=0.021), but not in the 
MoM group (p=0.174). This increase, however, did not correlate with an increase in mean 
cobalt concentration. There was no statistically significant increase of Co in any group at 
sixteen years compared to seven years (MoP p=0.355; MoM p=0.197). 
 
4.3 IMMUNOLOGICAL ANALYSIS, PAPER III 
Immunological analysis of the clinical cohorts was performed at a mean of seven years after 
the index operation. The mean concentrations of immunoglobulins and the number of 
leukocytes and lymphocytes were within the reference intervals for both groups and no 
significant differences were seen between groups (Table 5). Most tested subsets of 
lymphocytes were similar in the two groups except for the population of CD8+ T-cells 
positive for the HLA DR-antigen: 6.7 % in the MoP compared to 10.6 % in the MoM group 
(p=0.03). B-cells were found in a lower proportion of the total number of lymphocytes in the 
MoM group (9.3 % versus 12.9 % in the MoP group, p=0.01). There was no difference 
between groups regarding the total B-cell count.  
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Table 5. Immunological parameters. Mean differences of cells in numbers per nL, 
percentages or concentration of immunoglobulins in g/L, between the two bearing 
groups. Positive differences indicate higher values in the MoM group; negative indicate 
lower values in the MoM group. 
 Mean difference 95% CI p-value* 
Leukocytes –0.4 –1.3–0.5 0.4 
Lymphocytes 0.1 –0.4–0.5 0.8 
T-cells CD3 0.0 –0.4–0.4 0.9 
T-cells CD3 (%) 0.8 –4.6–6.2 0.8 
T-cells CD4 0.0 –0.3–0.2 0.7 
T-cells CD4 (%) –3.1 –9.5–3.3 0.3 
T-cells CD4 HLA DR+ 1.5 –1.3–4.2 0.3 
T-cells CD8 0.1 –0.1–0.3 0.4 
T-cells CD8 (%) 5.0 –1.6–11.5 0.1 
T-cells CD8 HLA DR+ 3.9 0.3–7.4 0.03 
CD4/CD8 ratio –1.9 –4.8–1.1 0.2 
B-cells CD19 0.0 –0.1–0.0 0.2 
B-cells CD19 (%) –3.7 –6.5–0.9 0.01 
NK-cells CD16/CD56 0.1 0.0–0.2 0.1 
NK-cells CD16/CD56 (%) 3.2 –1.8–8.3 0.2 
IgG 0.2 –1.7–2.1 0.84 
IgA 0.1 –0.9–1.1 0.79 
IgM –0.1 –0.5–0.2 0.39 
IgG1 0.3 –0.7–1.3 0.55 
IgG2 0 –1.2–1.2 0.99 
IgG3 –0.2 –0.5–0.2 0.31 
IgG4 0.1 –0.2–0.3 0.56 
*derived from independent t-test. Bold numbers indicate p<0.05. 
A statistically significant positive correlation of the percentage of HLA DR+ CD8+ T-cells 
with logarithmically transformed concentrations of Co (r=0.36, p=0.03) and Cr (r=0.39, 
p=0.02) was found (Figure 4). No significant correlations were found for other subsets. 
Figure 4. Correlation between the percentage of HLA DR+ CD8+ T-cells and metal ion 
concentrations. 
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4.4 CLINICAL PERFORMANCE OF STUDIED IMPLANTS, PAPERS II-IV 
The Harris hip score increased after surgery and remained at a high level during follow-up 
(Figure 5). No statistically significant differences were seen between groups. 
Figure 5. Harris hip score for metal-on-metal (MoM) and metal-on-polyethylene (MoP) 
THAs. 
 
The SF-36 at one and two years showed increased values for all eight domains in both groups 
compared to preoperative values (Table 6, next page). There were no statistically significant 
differences between the groups. 
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Table 6. SF-36 preoperatively and at the 12- and 24-months follow-up. 
  MoP N=23 MoM N=27 
  Mean SD Mean SD 
Physical scores (5 dimensions):     
Physical functioning 
Preop 40.0 24.6 32.6 22.6 
12 months 79.4 16.3 70.0 25.2 
24 months 77.0 19.3 67.2 26.9 
Social functioning 
Preop 71.2 26.8 71.8 23.4 
12 months 91.8 15.4 82.4 23.6 
24 months 88.0 20.5 83.3 27.1 
Role limitations 
    -Physical 
Preop 23.9 35.0 15.7 28.7 
12 months 70.7 38.2 61.1 44.6 
24 months 69.6 39.9 60.2 44.0 
Role limitations 
    -Emotional 
Preop 46.4 43.5 46.9 43.6 
12 months 78.2 38.4 64.2 44.3 
24 months 53.6 26.1 48.2 28.3 
Bodily pain 
Preop 39.3 19.2 33.3 19.4 
12 months 90.0 18.6 76.1 29.3 
24 months 76.7 27.9 67.9 31.7 
Mental scores (3 dimensions):     
Mental health 
Preop 69.2 21.8 69.0 20.5 
12 months 83.1 18.4 76.6 24.5 
24 months 80.2 18.9 73.8 20.4 
Energy/Vitality 
Preop 50.9 19.0 53.9 23.3 
12 months 77.6 22.1 67.8 26.2 
24 months 71.3 23.7 62.8 26.1 
General health 
perceptions 
Preop 69.1 20.8 68.3 23.0 
12 months 75.0 21.7 71.5 24.9 
24 months 70.0 20.8 66.1 26.0 
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4.5 RADIOLOGICAL OUTCOME, PAPERS II-IV 
The mean cup inclination angle measured at 16 years was similar in both groups (MoM 45° 
vs. MoP 48°, p=0.33), and none of the stems had migrated beyond five mm. No major 
difference regarding radiographic outcome was seen between the two groups at neither two-, 
seven- or 16-year follow-up. The frequency and distribution of radiolucent lines at the last 
follow-up are shown in Table 7 and 8. There was no statistically significant difference 
between the groups.  
Table 7. Presence of radiolucent lines 
at 16 years. 
Lucencies per 
patient (n) 
MoM 
(n=13) 
MoP 
(n=16) 
Cup   
   No lucency 7 6 
   1 zone 2 1 
   2 zones 4 7 
   3 zones 0 2 
Stem   
   No lucency 8 11 
   1 zone 4 3 
   2 zones 1 2 
p=0.23 in DeLee zones and p=0.85 in 
Gruen zones using Mann-Whitney U test 
on independent samples. 
Table 8. Distribution of radiolucent lines 
at 16 years. 
 MoM 
(n=13) 
MoP 
(n=16) 
No lucency in 
any DeLee zone 7 6 
DeLee zone 1 4 8 
 2 2 4 
 3 4 6 
No lucency in 
any Gruen zone 8 11 
Gruen zone 1 3 3 
 2-5 0 0 
 6 1 2 
 7 2 2 
 
                             
 
Figure 6. The Metasul MoM THA on the left and the Protasul MoP THA on the right. 
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4.6 LONG-TERM SURVIVAL OF STUDIED IMPLANTS, PAPER IV 
No patient suffered any complication, including deep infection, that needed surgery in the 
first two years after the index operation. A total of four patients underwent revision surgery 
during the study period, two in each group. Of these, one in each group had revision surgery 
due to aseptic loosening. Details of all revisions are shown in Table 9. 
Table 9. All revision cases in chronological order. 
Patient 
/ sex 
Years to 
revision Bearing 
Aseptic 
loosening Details 
1 / F 2.1 MoP No Cup revision (recurring dislocations). No signs of loosening. 
2 / M 9.5 MoP Yes Cup and stem revision (aseptic loosening). 
3 / M 12.7 MoM Yes Cup and stem revision (aseptic loosening). 
4 / M 13.0 MoM No Cup and stem revision (periprosthetic fracture). No signs of loosening. 
MoM=metal-on-metal, MoP=metal-on-polyethylene. There were no macroscopic signs 
of metallosis or pseudotumours during revision surgery in any case. 
 
Even though patients were not screened for pseudotumours with ultrasonography, CT or 
MRI, none presented with symptoms that indicated its presence at any time during follow-up. 
Long-term survival of the studied implants with aseptic loosening as the endpoint at 15 years 
was similar in both groups. The survival rate was 96 % in the MoM [95%-CI: 88-100%] and 
97 % in the MoP cohort [95%-CI: 91-100 %]. No statistically significant difference was seen 
between the groups (p=0.99) (Figure 7). 
Figure 7. Kaplan-Meier-analysis of metal-on-metal (MoM) and metal-on-polyethylene 
(MoP) articulations with revision for aseptic loosening as the endpoint. 
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Survival with revision for any reason as the endpoint was 93 % [95%-CI: 83-100 %] and 95 % 
[95%-CI: 87-100 %] in the MoM and MoP group, respectively. There was no significant 
difference between the groups (p=0.99) (Figure 8). 
Figure 8. Kaplan-Meier-analysis of metal-on-metal (MoM) and metal-on-polyethylene 
(MoP) articulations with revision for any reason as the endpoint. 
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5 DISCUSSION 
We evaluated a MoM THA with a 28-mm head both in a joint simulator and in a clinical 
setting. In a unique prospective, randomized study with long-term follow-up (mean 16 years), 
we compared the MoM bearing with a conventional MoP THA with identical properties 
except for the articulating surface. 
5.1 SURVIVAL AND CLINICAL OUTCOME OF THE 28-MM METASUL SYSTEM 
A Medline-search in December 2016 revealed nine long-term studies evaluating the 28-mm 
Metasul bearing (Table 10).52-60 Most of these studies were of a retrospective design, 
reporting the results of uncemented components in patients mostly younger than our cohort. 
Implant survival rates with revision for any reason as the endpoint were in most studies in 
line with our findings. Moreover, the proportions of patients revised due to aseptic loosening 
were also found to be similar when compared to our findings (Table 10). 
Table 10. Studies of long-term outcome (>12 years) of the 28-mm Metasul THA. 
 
There were only two other studies comparing the 28-mm MoM Metasul articulation with 
alternative bearings using a prospective randomized study design.57, 61 Bjørgul et al. reported 
a significantly lower survival rate and more radiolucent lines compared with the MoP and 
metal-on-ceramic (MoC) cohort after seven-year follow-up.61 Eight of the 112 MoM THAs 
were revised after seven years, of which four were due to aseptic loosening. The mean age of 
Bjørgul’s cohort (63 years) was comparable to that of our cohort and all implants were 
cemented. Migaud et al. compared uncemented MoM with MoC bearings in patients with a 
mean age of 40 years at the index surgery and a follow-up of 13 years. None of the 39 MoM 
THAs were revised, compared to 13 of 39 in the MoC control group.57 The results from these 
two studies are diverging, however our results support the findings of Migaud et al., showing 
good long-term survival of the 28-mm Metasul THA. 
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5.2 TRIBOLOGICAL FINDINGS AND WEAR 
A run-in phase of higher wear rates produced by MoM implants in a laboratory setting using 
a hip simulator has been described by others.62-64 The results in our clinical study did not 
clearly show a similar early phase with higher concentrations of metal ions in patient serum 
during the first year compared to later time-points. Our findings are consistent with those of 
other studies.65, 66 A theory that may explain these findings, is that an initial uptake of metals 
in the adjacent tissues with would prevent an actual accelerated early wear phase from 
causing elevated systemic metal concentrations compared to later time-points, when tissues 
are saturated. This hypothesis has not yet been investigated. 
In paper I, we found that two pairs of head-cup couplings showed higher wear rates compared 
to the other four pairs and never reached a steady state wear-phase. This may suggest that 
there could be patients exposed to higher loads of metal ions from metal wear because of 
microscopical characteristics or flaws of their individual implants. This has not been confirm-
ed in failed implant retrieval studies, where instead outliers with high metal ion concentra-
tions and above average wear were more likely to have mal-positioned implants.67  
MoM implants with larger head sizes have been shown to produce less wear than smaller 
diameter bearings in simulator studies.26 This may be explained by the wider surface area 
over which contact stresses are distributed and the formation of a thicker fluid film between 
head and socket under ideal circumstances, i.e. in a laboratory setting. The in vitro finding of 
increasing wear with diminishing head size, stands in contrast to the findings in clinical 
studies and retrieval studies. 16, 67, 68 In these studies, hip resurfacing systems and large head 
MoM THAs showed considerably more wear and higher systemic metal ion concentrations 
compared to smaller diameter MoM systems. One large retrieval study by Hart et al., 
reporting the examination of 276 revised large diameter MoM implants showed a high 
proportion of wear from edge loading on the bearings of the failed implants.67 This correlated 
only to some extent with a high cup inclination angle, which is known to cause edge 
loading.69 Hart et al. showed that in cases with a normal or low cup inclination angle, other 
factors may explain the edge-loading. Those factors could be e.g. impingement or peri-
operative deformation of cups with thin acetabular metal wall by design, such as the Articular 
Surface Replacement system (ASR, DePuy, Warsaw, IN, USA). A slightly deformed cup 
would result in equatorial loading of the articulating surfaces. This factor may in part explain 
the finding of high wear and failure rates in certain withdrawn resurfacing prostheses and 
mega head systems. The most common cause for revision in the study of Hart et al. was 
unexplained joint pain and most of the implants from these patients did not show extensive 
wear. This led the authors to speculate that they might suffer from a none dose-dependent 
hypersensivity to metal ions. 
Thus, there are conflicting results from in vitro studies of wear rates related to head diameter 
compared with in vivo studies of the same implants. This may generate the hypothesis that 
MoM THAs with small diameter heads, like the 28-mm head investigated in our study, may 
be more “forgiving” regarding implant positioning compared to large caliber head systems. 
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This, combined with the finding that some designs of large head systems have a higher risk of 
component deformation during implantation, indicates the need for further investigation in 
future studies. 
5.3 CONCENTRATIONS OF COBALT AND CHROMIUM 
The concentrations of Co and Cr in our clinical study were in accordance with other reports 
evaluating patients with the same 28-mm MoM articulation or similar small diameter MoM 
bearings from other manufacturers.53, 55-57, 70-72 
Some authors presented metal ion concentrations from whole-blood while others measured 
concentrations in serum or plasma. There is no evidence of the superiority of one method 
over the other.73 We measured concentrations in plasma until the seven-year follow-up, but 
had to change to serum at the 16-year follow-up due to a change of methodology at the 
external laboratory used throughout the study. In a study comparing the concentrations of 
metal ions in the different blood fractions, serum and plasma was found to be interchangeable 
regarding concentrations of Co and Cr.74 The same study showed that Co and Cr were found 
in lower concentrations in erythrocytes in patients with a MoM THA, resulting in lower 
concentrations of these ions in whole blood compared to plasma and serum. In healthy 
controls there were two to three times higher concentrations of Cr in erythrocytes compared 
to serum, in contrast to the distribution of ions found in MoM patients.74 This is explained by 
the fact that Cr is found physiologically in small amounts intracellularly, especially in 
erythrocytes. Plasma and serum in patients with a MoM THA contain according to one study, 
on average 1,5 times the amount of Co and Cr found in whole blood.75 The observed pattern 
of a higher concentration of Cr in extracellular fractions of blood after MoM THA indicates 
that Cr released from MoM bearings is of the less biologically active trivalent form, not being 
able to penetrate cellular membranes. Co is predominantly found extracellularly in both 
healthy controls and MoM THA patients.68, 74 
The significant elevation of Cr in both groups of our study at the follow-up at 16 years was 
not accompanied by a rise in Co. This may be the result of corrosion or wear from the head-
neck junction, so-called trunnionosis.76 An alternative explanation could be the change of 
method of sample collection and equipment at the latest follow-up, an undesired and unfortu-
nate side effect of the long-term setup. 
There are guidelines stating that patients with MoM implants should be monitored and 
screened for elevated metal concentrations regardless of symptoms.40-42 This screening is 
recommended to detect early cases of ARMD that may need revision surgery. A cut-off level 
of seven µg/L for Co and Cr in whole-blood has been set by the FDA and MHRA, above 
which further action should be taken. Even though ion concentrations are believed to reflect 
the amount of wear from bearings, and elevated levels are associated with a higher risk of 
revision, there is little evidence to support this screening method as the only predictor of the 
patients’ risk of revision due to implant failure.20, 77-79 There are reports stating that above-
average concentrations of Co and Cr may correlate with the development of pseudotumours 
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and there are yet other studies contradicting such a relationship.21, 80, 81 The findings of 
pseudotumours is not a certain predictor for clinical symptoms or mechanical failure leading 
to revision.79, 82 
5.4 SYSTEMIC EFFECTS OF COBALT AND CHROMIUM FROM METAL-ON-
METAL IMPLANTS 
The effect on lymphocyte counts in relation to the concentration of circulating Co and Cr ions 
after THA has been investigated, but the results are inconclusive.83-85 Retrospective studies 
indicate that higher metal concentrations correlate with a decrease in circulating CD8+ lym-
phocytes.83, 84 The only prospective, randomized study including baseline levels of cellular 
immunology and metal ions showed a small but statistically significant depressive effect of 
Co ions on the general T-cell count.85 This is in contrast to the findings of our study, which 
documented a correlation between an increase of the sub-group of CD8+ cells expressing 
HLA-DR and higher metal concentrations. The clinical significance of this finding is how-
ever unclear. 
In a recent study, tissues from pseudotumours of patients with failed ASR implants were 
shown to exhibit a macrophage dominated reaction in patients with higher systemic concen-
trations of Co and Cr.86 In the same study, patients with lower systemic concentrations of 
metals, comparable to the level seen in our study, showed a lymphocyte driven inflammation. 
This would suggest two separate types of failure mechanisms; one caused by a cytotoxic 
reaction to high level of metals driven by macrophages and one with the characteristics of a 
delayed-type hypersensitivity reaction, mediated by lymphocytes.86 
Co and the hexavalent form of Cr are known to have various biological effects and even 
cause morbidity in humans at high concentrations.31-33, 36, 87-92 Hence, it has been motivated to 
investigate their potential role in the development of cancers after MoM THA. In several 
Nordic studies, data from the national hip arthroplasty registries was analyzed and matched 
with data from national cancer registries. Cancer incidences in patients with MoM and MoP 
hip implants were compared with each other and with the cancer burden in a selected, 
matched population without prostheses, as well as with that of the general population. Even 
though studies did not show an increased total risk of cancer or mortality for other reasons 
associated with MoM implants, there are indications of a higher rate of basal cell carcino-
mas.93-96 This type of cancer is known to be more common in patients with a compromised 
immune system following organ transplantation and is believed to be especially related to a 
lower CD4+ T-cell count.97 Another recent study of the first seven years after implantation of 
a MoM THA, based on the National Joint Registry in Great Britain, showed no increased risk 
of cancer.98 Since the registry did not start collecting data until 2003, the follow-up is shorter 
than those of the Nordic studies. 
Although metal ions at concentrations normally seen after MoM THA are not believed to 
cause systemic morbidity, there are case reports of severe conditions in patients with 
extremely elevated concentrations of Co and Cr after THA surgery.18, 99, 100 
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Toxic concentrations of 100-5,000 times the levels seen in our study, are not uncommon in 
those case reports and patients often show various symptoms and conditions associated with 
Co poisoning, e.g. peripheral neuropathy, sensorineural hearing loss, visual impairment, 
cardiomyopathy and hypothyroidism.19 Poisoning from extreme levels of Co associated with 
a MoM THA can even be fatal.89, 101 Some of the cases with ultra-high levels of Co and Cr 
are revised patients where a THA with shattered ceramic bearings have been replaced with a 
MoM or MoP THA.100 In these cases, friction from microscopic ceramic shards between the 
articulating surfaces will lead to large amounts of metal wear. 
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6 LIMITATIONS 
 
The power calculation that was performed prior to our clinical study revealed the need of a 
cohort of at least 20 patients in each arm to detect significant differences concerning the 
primary outcome (metal concentrations during the run-in phase). With time, other outcomes 
were added to the study, e.g. long-term survival and immunological analyses, with the risk of 
a type two error as the number of patients diminished during follow-up due to death and other 
causes. Regarding the difference in immunological parameters between groups at seven 
years, there was both a risk of type one and type two error. 
Because only 30 of 85 patients could be evaluated at the 16-year follow-up, we chose not to 
exclude patients that had received additional implants. This should be considered when 
comparing the metal ion concentrations of this study to those of other studies, even though 
none of the patients had an additional MoM implant and the presence of additional implants 
was similar in both groups at 16 years (MoM=nine out of 14 patients vs. MoP=10 out of 16 
patients; p=0.61). 
The small differences in the method of gathering blood and the preparation of serum for the 
measurement of metal ion concentrations at the 16-year follow-up compared with earlier 
time-points may have resulted in a potential methodological error. This could affect the com-
parison of Cr concentrations with earlier follow-ups but not the comparisons between groups 
at this time-point. 
The analysis of immunological differences between groups would have greatly benefitted 
from preoperative baseline values of the immunological status of the patient cohort, which 
our study lacked. 
The patient cohort and exclusion of patients was not fully described in paper II and not 
presented in accordance with the CONSORT statement. This was not a requirement at the 
time of publication. The cohort is described more accurately in the patients and methods 
section of this thesis. 
The acetabular components of both the MoM and the MoP were made from UHMWPE, a 
predecessor to the highly crosslinked PE which was first introduced into the market soon 
after the initiation of our clinical study. Since most cups today are made from highly cross-
linked PE, the use of a cup made from this material in the MoP control group of our clinical 
study would have been preferred. 
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7 CONCLUSIONS 
 
This thesis concludes the following: 
1. MoM implants show a wear pattern in vitro consisting of an early high wear run-in 
phase, followed by a steady-state phase with a significantly lower wear rate. 
2. Patients with a MoM THA have significantly higher systemic concentrations of Co 
and Cr compared to patients with a MoP THA at all time-points during 16 years of 
follow-up. 
3. There is evidence suggesting that increasing systemic concentrations of Co and Cr 
correlate with changes in lymphocyte subsets. 
4. The over-all clinical performance and long-term survival of a 28-mm all-cemented 
Metasul MoM THA is similar to that of a comparable conventional Protasul MoP 
THA. 
5. There is no superiority of any of the investigated bearings when compared with each 
other, hence we recommend the use of the MoP articulation to avoid the subsequent 
life-long exposure of biologically active metal ions from MoM THAs. 
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8 FUTURE PERSPECTIVES 
 
As mentioned previously, it is estimated that over one million patients worldwide presently 
live with a MoM implant. Many of these patients were operated at a relatively young age. 
The matter of what happens to them in the event of future kidney failure has not been 
thoroughly investigated.102 Since the circulating metal ions from MoM bearings are excreted 
via the kidneys, hopefully there will be future investigations shedding more light on this 
issue. 
The concept of MoM implants has historically been introduced twice and both times been 
found to be inferior to other articulations. Since we all know the saying that the third time is a 
charm, it would not be surprising if a re-introduction of MoM is seen some twenty years from 
now. The take-home message from this thesis to future manufacturers would be to remember 
that: 
• tribological findings in vitro do not always correspond to actual performance in vivo 
• metals with known biological activity and toxicity are not suitable in alloys of rigid 
bearing surfaces 
• clinical series with long-term follow-up are essential in the introduction of new 
implant systems, preferably before they are widely introduced on the market. 
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9 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Bakgrunden till att mycket forskning ägnas åt att optimera de metoder och material som 
används vid höftproteskirurgi är det utgör ett av de vanligaste kirurgiska ingreppen i vårt land 
och i övriga västvärlden. I Sverige utförs årligen drygt 16 000 höftprotesoperationer. 
På femtiotalet började operationer med konstgjorda ledproteser utföras i ökande skala på 
människor med smärtande höftleder. Höftproteskirurgi utnämndes redan efter några årtionden 
med rätta till ”århundradets operation”. I flera av de tidigaste protesmodellerna var både 
lårbenets ledhuvud och bäckenets ledpanna ersatta av protesdelar gjorda helt av metall, så 
kallade metall-mot-metall (M-M) proteser. Inom några år utmanades M-M modellen av andra 
protessystem, i vilka ett litet metallhuvud istället ledade mot en ledpanna av polyetylenplast. 
Den mest berömda protesen med ledytor av metall-mot-polyetylen (M-P) har uppkallats efter 
sin skapare, sir John Charnley. Med den så kallade Charnley-protesen erhölls minimal 
friktion mellan de rörliga delarna och en ”golden standard” sattes för höftproteser. M-P 
visade mycket goda initiala resultat och medförde att M-M-proteserna konkurrerades ut under 
sjuttiotalet. Det finns dock fortfarande människor i livet med välfungerade M-M-proteser från 
sextio- och sjuttiotalen kvar i sina höfter. 
Materialet till denna avhandling kommer från innehållet i två studier. I den första har M-M-
protesen Metasul testats i en höftsimulator och mängden nötning från sex protesers ledytor 
har mätts regelbundet under drygt fyra miljoner cykler, motsvarande fyra års normalt använd-
ande i kroppen efter operation. Resultatet visar att nötningen av ledytorna i de flesta fall var 
störst under det första året och därefter planade ut på en lägre nivå. Den andra studien är en 
klinisk studie som omfattar 85 patienter med höftartros. Hälften lottades till att opereras med 
en likadan M-M-protes som i den första studien och hälften lottades till en kontrollgrupp som 
fick liknande proteser men med slitytor av M-P. Grupperna följdes sedan under 17 år med 
regelbundna kontroller av höftfunktion, röntgenutseende och blodkoncentrationer av metall-
erna kobolt (Co) och krom (Cr) som ingår i höga halter i protesernas metallegeringar. Sju år 
efter operationerna kontrollerades även patienternas immunförsvar. 
Resultaten visar att båda protestyperna gav en god och likvärdig funktion. Runt proteserna 
syntes röntgenförändringar i lika hög utsträckning i båda grupperna. Endast två patienter i 
varje grupp hade efter 15 år behövt opereras om i sina höfter, vilket anses vara ett gott resultat 
och i linje med andra studiers resultat avseende liknande proteser. Halterna av Co och Cr i 
blodet var högre i patientgruppen med M-M-proteser jämfört med M-P-gruppen vid alla 
mättillfällen efter operationen. Sju år efter operationen syntes små men mätbara skillnader i 
halterna av vissa typer av vita blodkroppar. Andra studier har också sett skillnader i immun-
försvaret efter operation med M-M-proteser. Man vet sedan tidigare att Co och Cr, i betydligt 
högre halter än de vi fann i vår studie, kan medföra allvarliga sjukdomar. 
Slutsatsen i denna avhandling är att man på grund av risken för oklara biologiska effekter i 
kroppen på lång sikt inte rekommenderar användande av M-M-proteser, trots goda och lik-
värdiga resultat jämfört med de traditionella modellerna med ledytor av M-P. 
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